Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

European Medicines Agency
News & Press Releases
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022 (updated)
CHMP, Last updated: 02/02/2022
EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its January 2022 meeting.
The antiviral Paxlovid (PF-07321332 / ritonavir) received a positive opinion from the Committee for a conditional marketing authorisation for the treatment of COVID-19. More details are available in a separate news announcement…

 

 

News: A stronger role for EMA (new)
Last updated: 31/01/2022
The regulation reinforcing EMA’s role in crisis preparedness and management for medicinal products and medical devices has been published today in the Official Journal of the EU. This officially concludes the legislative process for an important pillar of the European Health Union.
The new regulation enters into force on the day following this publication and becomes applicable as of 1 March 2022, except for the provisions on shortages of critical medical devices which will apply as of 2 February 2023. It puts structures and processes established by EMA during the COVID-19 pandemic on a permanent footing, while entrusting several new tasks to the Agency…

 

 

::::::

 

European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates
Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA
Technical report 31 Jan 2022
This report provides an updated overview of the progress with national COVID-19 vaccination strategies and deployment in European Union/European Economic Area (EU/EEA) countries, including updates on:
– overall vaccine uptake and uptake by target group;
– vaccination strategies and policies;
– challenges and good practice with the roll-out, including vaccine acceptance and uptake.

 

 

::::::

Accessed 05 Feb 2022
https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab

 

 

::::::

 

 

European Commission
https://ec.europa.eu/commission/presscorner/home/en
No new digest content identified.